Literature DB >> 4392958

Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.

E J Mylecharane, C Raper.   

Abstract

1. The beta-adrenoceptor antagonists propranolol, pronethalol, MJ 1999 and Ciba 39089-Ba reduced responses to field stimulation of the guinea-pig isolated vas deferens preparation without significantly affecting responses to exogenously added noradrenaline.2. This prejunctional blocking action of the drugs cannot be correlated with their action as beta-adrenoceptor antagonists or non-specific depressants.3. The blockade produced was more pronounced at low (5-20 Hz) than at high (50 Hz) frequencies of stimulation.4. The blockade was slow in onset, and once established was poorly reversed by washing the preparation over a period of 1 to 2 h.5. The blockade produced could be reversed by dexamphetamine and cocaine.6. These experiments suggest that the beta-adrenoceptor antagonists may have some actions which closely resemble those of the adrenergic neurone blocking agent guanethidine.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4392958      PMCID: PMC1703050          DOI: 10.1111/j.1476-5381.1970.tb09562.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

Review 1.  ADRENERGIC NEURONE BLOCKING AGENTS.

Authors:  A L BOURA; A F GREEN
Journal:  Annu Rev Pharmacol       Date:  1965       Impact factor: 13.820

2.  A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.

Authors:  J R Schmid; C Hanna
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

3.  Antisympathomimetic and antifibrillatory effects of pronethalol and propranolol.

Authors:  B G Benfey; D R Varma
Journal:  Br J Pharmacol Chemother       Date:  1966-01

4.  Propranolol, MJ 1999 and Ciba 39089 Ba in ouabain and adrenaline induced cardiac arrhythmias.

Authors:  C Raper; J Wale
Journal:  Eur J Pharmacol       Date:  1968-08       Impact factor: 4.432

5.  Some studies on the mechanism by which d-amphetamine antagonizes guanethidine induced adrenergic neurone blockade.

Authors:  H O Obianwu
Journal:  Acta Physiol Scand       Date:  1969 Jan-Feb

6.  Effect of cocaine, phenoxybenzamine and calcium on the inhibition of norepinephrine output from the cat spleen by guanthidine.

Authors:  S M Kirpekar; A R Wakade; W Dixon; J C Prat
Journal:  J Pharmacol Exp Ther       Date:  1969-02       Impact factor: 4.030

7.  Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).

Authors:  P Aramendía; A J Kaumann
Journal:  J Pharmacol Exp Ther       Date:  1967-02       Impact factor: 4.030

8.  Propranolol in hypertension.

Authors:  B N Prichard; P M Gillam
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

9.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04

10.  The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart.

Authors:  J W Foo; A Jowett; A Stafford
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

View more
  12 in total

1.  Some aspects of the pharmacology of beta-adrenorecptor blockers.

Authors:  B Ablad; E Carlsson; C Dahlŏf; L Ek
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Effects of beta-adrenoreceptor blocking drugs on adrenergic transmission.

Authors:  M Rand; M Law; D F Story; M W McCulloch
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

4.  Stimulation of presynaptic beta-adrenoceptors enhances [3H]-noradrenaline release druing nerve stimulation in the perfused cat spleen.

Authors:  S M Celuch; M L Dubocovich; S Z Lander
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

5.  The uptake and overflow of radiolabelled beta-adrenoceptor blocking agents by the isolated vas deferens of the rat.

Authors:  M J Lewis
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

6.  Factors influencing the adrenergic neurone blocking action of propranolol.

Authors:  S Eliash; M Weinstock
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

7.  The effect of propranolol on vascular responses to sympathetic nerve stimulation.

Authors:  P M Dawes; D C Faulkner
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

8.  Adrenoceptor functions in the cat choledochoduodenal junction in vitro.

Authors:  C G Persson
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

9.  Role of adrenergic neurone blockade in the hypotensive action of propranolol.

Authors:  S Eliash; M Weinstock
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

10.  Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.

Authors:  H S Mueller; S M Ayres
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.